| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2012-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41e332d7560c656887569aa63341f801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ded9ad54bb897add63cf84ec3c85a16b |
| publicationDate |
2012-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012229242-A |
| titleOfInvention |
Anthraquinone drug-containing laxative pharmaceutical composition |
| abstract |
Disclosed is a pharmaceutical composition capable of regulating the action of an anthraquinone drug which is a stimulant laxative. A pharmaceutical composition comprising at least one ingredient selected from the group consisting of vitamin B1 and its derivatives and salts thereof in a dairy or its extract or cocoon ingredient. In which Daio or its extract or cocoon ingredient is blended in Daikokanzoto, vitamin B1 and its derivatives and salts thereof are thiamine, thiamine disulfide, prosultiamine, fursultiamine etc. and their salts preferable. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104257769-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104257770-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104257768-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105362650-A |
| priorityDate |
2005-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |